Triple combination of FDA-approved drugs including flufenamic acid, clarithromycin and zanamivir improves survival of severe influenza in mice.

Published in:

Archives of Virology, 2018, v. 163, n. 9, p. 2349, doi. 10.1007/s00705-018-3852-4

By:

• Lee, Andrew C. Y.;
• To, Kelvin K. W.;
• Zhang, Anna J. X.;
• Zhu, Houshun;
• Li, Can;
• Zhang, Ricky R.;
• Hung, Ivan F. N.;
• Kao, Richard Y. T.;
• Chan, Kwok-Hung;
• Yuen, Kwok-Yung

Publication type:

Article